US FTC secures injunction in Edwards-JenaValve merger challenge
Medical device maker Edwards Lifesciences’ proposed acquisition of rival JenaValve Technology, which the US Federal Trade Commission challenged and characterized as a merger to monopoly for a life-saving cardiac device, was...To view the full article, register now.
Already a subscriber? Click here to view full article